Other
Infants
0
Pipeline Programs↗
16
Active Trials↗
20
Companies Involved↗
Infants is an early-stage landscape with 0 programs across 20 companies. The most active players are Merck & Co., Pfizer, Shanghai Ark Biopharmaceutical Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
106
clinical trials
Completed65 · 61%
Terminated10 · 9%
Recruiting9 · 8%
Unknown status7 · 7%
Withdrawn6 · 6%
Not yet recruiting4 · 4%
Other5 · 5%
Clinical Trials
Trial Activity
106 trials
Inhaled Ciclesonide Study in Preterm Infants
Recruiting·—·Phase 1·NCT06589245·30 enrolled
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Recruiting·—·N/A·NCT03511118·1,600 enrolled
Use of Hyperpolarized 129Xe MR Lung Imaging in Infants
Recruiting·—·Phase 4·NCT04995562·12 enrolled
PK/PD of Digoxin in Infants With SVHD
Recruiting·—·Phase 1/2·NCT06613477·20 enrolled
Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants
Recruiting·IInstituto de Investigación Hospital Universitario La Paz·Phase 1/2·NCT06878742·30 enrolled
L9LS MAb in Malian Infants
Active, not recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT06461026·180 enrolled
Tolerability of Enteral NAC in Infants
Not yet recruiting·—·Phase 1·NCT06260566·12 enrolled
Page 1 of 8
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)